Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences

齐欢畅

Arrowhead Pharmaceuticals to Participate in Upcoming December 2019 Conferences
Nov 26, 2019 at 4:00 PM EST
PASADENA, Calif. --(BUSINESS WIRE)--Nov. 26, 2019-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events: Piper Jaffray 31st Annual Healthcare Conference – New York , December 3-5, 2019 December 3 , 11:00 a.m.
PDF Version
PASADENA, Calif.--(BUSINESS WIRE)--Nov. 26, 2019-- Arrowhead Pharmaceuticals Inc. (NASDAQ: ARWR) today announced that it is scheduled to participate in the following upcoming events:

Piper Jaffray 31st Annual Healthcare Conference – New York, December 3-5, 2019

December 3, 11:00 a.m. EST – Chris Anzalone, Ph.D., Arrowhead’s president and CEO, will participate in a fireside chat presentation with Edward Tenthoff, managing director and senior research analyst at Piper Jaffray

HEP DART 2019 – Kauai, Hawaii, December 8-12, 2019

December 10, 6:00 p.m. HST – Bruce Given, M.D., Arrowhead’s chief operating officer and head of R&D, will deliver an oral presentation titled, “Where will RNAi fit in the era of finite therapies”

A copy of the presentation materials and webcast links, if the presentation is being webcast, may be accessed on the Events and Presentations page under the Investors section of the Arrowhead website.